Journal of Neurochemistry · 2002 · 56 citations · 15 references
Life SciencesBiochemistryNeuroscienceEnzymologyMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseAmyloid FormationEnzyme FunctionNeurodegenerative DiseasesNeurodegenerative DisordersAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid Plaque FormationAmyloid StructureArachidonic Acid MetabolitesCyclooxygenase Pathways
Epidemiologic evidence implicates cyclooxygenase activity in the pathogenesis of Alzheimer's disease, in which amyloid plaques have been found to contain increased levels of dimers and higher multimers of the amyloid beta peptide. The product of the oxygenation of arachidonic acid by the cyclooxygenases, prostaglandin H2 (PGH2), rearranges non-enzymatically to several prostaglandins, including the highly reactive gamma-keto aldehydes, levuglandins E2 and D2. We demonstrate that PGH2 markedly accelerates the formation of dimers and higher oligomers of amyloid beta1-42. This is associated with the formation of levuglandin adducts of the peptide. These findings provide the molecular basis for a hypothesis linking cyclooxygenase activity to the formation of oligomers of amyloid beta.
15
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
Bas A. in 't Veld, Annemieke Ruitenberg, Albert Hofman et al. · New England Journal of Medicine · 2001 · 1.2K citations · Full text